Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
Irene Schiavetti, Marta Ponzano, Alessio Signori, Francesca Bovis, Luca Carmisciano, Maria Pia Sormani
Topics & Concepts
MedicineRituximabOcrelizumabMeta-analysisChecklistMEDLINESystematic reviewMultiple sclerosisAsymptomaticPneumoniaInternal medicinePediatricsIntensive care medicineImmunologyPolitical scienceLymphomaPsychologyCognitive psychologyLawLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research Studies